Publications

Health Economics

Return to Publications
  1. Daccache C, Karam R, Evers SMAA, Hiligsmann M, Rizk R. Developing the Lebanese health economic evaluation guideline. Expert Rev Pharmacoecon Outcomes Res. 2023 Nov 6. doi: 10.1080/14737167.2023.2280213. https://pubmed.ncbi.nlm.nih.gov/37929564
  2. Dahham J, Hiligsmann M, Kremer I, Khoury SJ, Darwish H, Hosseini H, Evers S, Rizk R. The societal costs of multiple sclerosis in Lebanon: a cross-sectional study. Expert Rev Pharmacoecon Outcomes Res. 2023 Feb 23. doi: 10.1080/14737167.2023.2184802. https://pubmed.ncbi.nlm.nih.gov/36820619
  3. Dahham J, Kremer I, Hiligsmann M, Hamdan K, Nassereddine A, Evers SMAA, Rizk R. Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon. Appl Health Econ Health Policy. 2022 Oct 26. doi: 10.1007/s40258-022-00769-2. https://pubmed.ncbi.nlm.nih.gov/36287378
  4. Karam MM, Abdel Baki J, Al Hajje A, Sraj M, Awada S, Salameh P, Ajrouche R. Author Reply. Value Health Reg Issues. 2022 Jul;30:166-167. doi: 10.1016/j.vhri.2022.04.003. Epub 2022 May 10. PMID: 35561549. https://pubmed.ncbi.nlm.nih.gov/35561549
  5. Karam MM, Baki JA, Al-Hajje A, Sraj M, Awada S, Salameh P, Ajrouche R. Willingness to Pay for a Coronavirus Vaccine and Its Associated Determinants in Lebanon. Value Health Reg Issues. 2022 Jan 13;30:18-25. doi: 10.1016/j.vhri.2021.10.004. https://pubmed.ncbi.nlm.nih.gov/35033800
  6. Daccache C, Rizk R, Dahham J, Evers SMAA, Hiligsmann M, Karam R. Economic evaluation guidelines in low- and middle-income countries: a systematic review. Int J Technol Assess Health Care. 2021 Dec 21;38(1):e1. doi: 10.1017/S0266462321000659. PMID: 34931601. https://pubmed.ncbi.nlm.nih.gov/34931601
  7. Dahham J, Rizk R, Hiligsmann M, Daccache C, Khoury SJ, Darwish H, Evers S, Kremer I. The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol. Expert Rev Pharmacoecon Outcomes Res. 2021 Nov 26:1-8. doi: 10.1080/14737167.2022.2008242. Epub ahead of print. PMID: 34826264. https://pubmed.ncbi.nlm.nih.gov/34826264
  8. Iskandar K, Roques C, Hallit S, Husni-Samaha R, Dirani N, Rizk R, Abdo R, Yared Y, Matta M, Mostafa I, Matta R, Salameh P, Molinier L. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective. BMC Infect Dis. 2021 May 1;21(1):404. doi: 10.1186/s12879-021-06084-w. PMID: 33933013; PMCID: PMC8088567. https://pubmed.ncbi.nlm.nih.gov/33933013
  9. Dahham J, Rizk R, Kremer I, Evers SMAA, Hiligsmann M. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review. Pharmacoeconomics. 2021 May 6. doi: 10.1007/s40273-021-01032-7. Epub ahead of print. PMID: 33956330. https://pubmed.ncbi.nlm.nih.gov/33956330
  10. Lahoud N, Rizk R, Hleyhel M, Baaklini M, Zeidan RK, Ajaka N, Rahme D, Maison P, Saleh N. Trends in the consumption of antibiotics in the Lebanese community between 2004 and 2016. Int J Clin Pharm. 2021 Jan 7. doi: 10.1007/s11096-020-01218-7. Epub ahead of print. PMID: 33411181. https://pubmed.ncbi.nlm.nih.gov/33411181
  11. Iskandar K, Rizk R, Matta R, Husni-Samaha R, Sacre H, Bouraad E, Dirani N, Salameh P, Molinier L, Roques C; “Economics of the Antibiotic Resistance Research” Group, Dimassi A, Hallit S, Abdo R, Hanna PA, Yared Y, Matta M, Mostafa I. Economic Burden of Urinary Tract Infections from Antibiotic-Resistant Escherichia coli Among Hospitalized Adult Patients in Lebanon: A Prospective Cohort Study. Value Health Reg Issues. 2021 Jan 22;24:38-46. doi: 10.1016/j.vhri.2020.01.006. Epub ahead of print. PMID: 33494034. https://pubmed.ncbi.nlm.nih.gov/33494034
  12. Fasseeh A, Karam R, Jameleddine M, George M, Kristensen FB, Al-Rabayah AA, Alsaggabi AH, El Rabbat M, Alowayesh MS, Chamova J, Ismail A, Abaza S, Kaló Z. Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status. Front Pharmacol. 2020;11:15. Published 2020 Feb 21. doi:10.3389/fphar.2020.00015. https://pubmed.ncbi.nlm.nih.gov/32153393
  13. Iskandar K, Sartelli M; Tabbal M; Ansolini L; Baiocchi GL; Catena F, Coccolini F; Haque M, Labricciosa FM; Moghabghab A; Pagani L; Abi Hanna P; Roques C; Salameh P; Molinier L. Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial resistant bacteria. World Journal of Emergency Surgery, 2019; 14: 50. https://www.ncbi.nlm.nih.gov/pubmed/31832084
  14. Abdo RR, Abboud HM, Salameh PG, Jomaa NA, Rizk RG, Hosseini HH. Direct Medical Cost of Hospitalization for Acute Stroke in Lebanon: A Prospective Incidence-Based Multicenter Cost-of-Illness Study. Inquiry. 2018 Jan-Dec;55:46958018792975. doi: 10.1177/0046958018792975. https://www.ncbi.nlm.nih.gov/pubmed/30111269
  15. El‐Jardali F, Fadlallah R, Daouk A, Rizk R, Hemadi N, El Kebbi O, Farha A, Akl EA. Barriers and facilitators to implementation of essential health benefits package within primary health care settings in low‐income and middle‐income countries: A systematic review. Int J Health Plann Manage. 2019 Jan;34(1):15-41. doi: 10.1002/hpm.2625. Epub 2018 Aug 22. https://www.ncbi.nlm.nih.gov/pubmed/30132987
  16. Radwan H, Ballout RA, Hasan H, Lessan N, Karavetian M, Rizk R. The Epidemiology and Economic Burden of Obesity and Related Cardiometabolic Disorders in the United Arab Emirates: A Systematic Review and Qualitative Synthesis. J Obes. 2018 Dec 3;2018:2185942. doi: 10.1155/2018/2185942. eCollection 2018. https://www.ncbi.nlm.nih.gov/pubmed/30652030
  17. Karavetian M, Rizk R. Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs? Kidney Res Clin Pract. 2018 Mar;37(1):4-7. doi: 10.23876/j.krcp.2018.37.1.4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875571/
Return to Publications